Dergiler / Ulusal Travma ve Acil Cerrahi Dergisi / 2019 / Cilt: 25 - Sayı: 4

Assessing the therapeutic effect of resveratrol in heart failure following blunt chest trauma and the potential role of endocan as a biomarker of inflammation using rats

Sıçanlarda künt göğüs travma sonrası oluşan kalp hasarı üzerine resveratrolün tedavi edici etkisinin ve endokanın enflamasyonda bir biyobelirteç olarak potansiyel rolünün değerlendirilmesi

Sayfa
343–349
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We believe that there is a need for further studies on the clinical use of endocan as a biomarker of inflammation in cardiac injury after blunt chest trauma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:BACKGROUND: The present study investigated the therapeutic effect of resveratrol on cardiac injury resulting from blunt chest trauma and the utility of endocan as a biomarker of the inflammation process using rats.
📊
Temel Bulgular & Veri:METHODS: The rats were randomly divided into the following four groups (n=7 in each group): a control group (no treatment or trauma); trauma-induced group (trauma group); resveratrol group (resveratrol 0.3 mg/kg administered via the intraperitoneal [i.p.] route group); and resveratrol + trauma group (resveratrol 0.3 mg/kg administered via the i.p. route 1 hour prior to the induction of trauma).
💡
Sonuç & Katkı:We believe that there is a need for further studies on the clinical use of endocan as a biomarker of inflammation in cardiac injury after blunt chest trauma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

BACKGROUND: The present study investigated the therapeutic effect of resveratrol on cardiac injury resulting from blunt chest trauma and the utility of endocan as a biomarker of the inflammation process using rats. METHODS: The rats were randomly divided into the following four groups (n=7 in each group): a control group (no treatment or trauma); trauma-induced group (trauma group); resveratrol group (resveratrol 0.3 mg/kg administered via the intraperitoneal [i.p.] route group); and resveratrol + trauma group (resveratrol 0.3 mg/kg administered via the i.p. route 1 hour prior to the induction of trauma). RESULTS: The immunoreactivity of tumor necrosis factor-α and inducible nitric oxide synthase in the trauma group was increased, whereas the reaction intensity in resveratrol + trauma group was deceased. The mean endocan values of the differed between the groups (p<0.001). The mean endocan value in the resveratrol + trauma group was higher than that of the other groups. CONCLUSION: Resveratrol exhibited anti-inflammatory and antioxidant effects in lung injury after blunt chest trauma and contributed favorably to the treatment process. We believe that there is a need for further studies on the clinical use of endocan as a biomarker of inflammation in cardiac injury after blunt chest trauma.

Abstract

AMAÇ: Bu çalışma, sıçanlarda künt göğüs travmasına bağlı gelişen kardiyak hasar üzerine resveratrolün terapötik etkisini ve endokanın enflamasyon sürecinde bir biyobelirteç olarak kullanılmasını araştırmıştır. GEREÇ VE YÖNTEM: Sıçanlar randomize olarak aşağıdaki dört gruba ayrıldı (her grupta, n=7): bir kontrol grubu (tedavi veya travma olmadan); travma uygulanan grup (travma grubu); resveratrol grubu (resveratrol, [0.3 mg/kg] intraperitoneal [i.p.] yol grubu yoluyla uygulandı); ve resveratrol + travma grubu (travmanın uygulanmasından 1 saat önce i.p. yolla resveratrol [0.3 mg/kg] verilen). BULGULAR: Travma grubundaki tümör nekroz faktörü-α ve indüklenebilir nitrik oksit sentazın immünreaktivitesi artarken, resveratrol + travma grubundaki reaksiyon şiddeti azaldı. Grupların ortalama endokan değerleri farklıydı (p<0.001). Resveratrol + travma grubundaki ortalama endokan ortalaması diğer gruplardan daha yüksekti. TARTIŞMA: Resveratrol, künt göğüs travması sonrası akciğer hasarında anti-enflamatuvar ve antioksidan etkilere sahip olup tedavi sürecine katkıda bulunmuştur. Künt göğüs travması sonrası oluşan kardiyak hasarda enflamasyonun takibinde endokanın bir biyobelirteç olarak klinik kullanımı ile ilgili daha fazla çalışma yapılması gerektiğine inanıyoruz.

🔖

Bu Makaleye Atıf Yap

TORUN, A. Ç., TÜTÜNCÜ, Ş. (2019). Assessing the therapeutic effect of resveratrol in heart failure following blunt chest trauma and the potential role of endocan as a biomarker of inflammation using rats. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 25 - Sayı: 4, 343–349. https://ajindex.com/articles/323568

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Raj P, Louis XL, Thandapilly SJ, Movahed A, Zieroth S, Netticadan T. Potential of resveratrol in the treatment of heart failure. Life Sci 2014
  2. 63–71. [CrossRef ] 2. Raj P, Zieroth S, Netticadan T. An overview of the efficacy of resveratrol in the management of ischemic heart disease. Ann N Y Acad Sci 2015
  3. 55–67. [CrossRef ] 3. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol 2012
  4. [CrossRef ] 4. Zhang HX, Duan GL, Wang CN, Zhang YQ, Zhu XY, Liu YJ. Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress. Pulm Pharmacol Ther 2014
  5. 150–5. [CrossRef ] 5. Cho S, Namkoong K, Shin M, Park J, Yang E, Ihm J, et al. Cardiovascular Protective Effects and Clinical Applications of Resveratrol. J Med Food 2017
  6. 323–34. [CrossRef ] 6. Robich MP, Osipov RM, Chu LM, Han Y, Feng J, Nezafat R, et al. Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia. Eur J Pharmacol 2011
  7. 45–53. [CrossRef ] 7. O’Leary KA, de Pascual-Teresa S, Needs PW, Bao YP, O’Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 2004
  8. 245–54. [CrossRef ] 8. Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, et al. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008
  9. 1263–9. [CrossRef ] 9. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2009
  10. H1876– 81. [CrossRef ] 10. Emet M, Akoz A, Aslan S, Saritas A, Cakir Z, Acemoglu H. Assessment of cardiac injury in patients with blunt chest trauma. Eur J Trauma Emerg Surg 2010
  11. 441–7. [CrossRef ] 11. Demir F, Güzel A, Kat C, Karadeniz C, Akdemir U, Okuyucu A, et al. A combination of methylprednisolone and quercetin is effective for the treatment of cardiac contusion following blunt chest trauma in rats. Braz J Med Biol Res 2014
  12. 766–72. [CrossRef ] 12. De’Ath HD, Manson J, Davenport R, Glasgow S, Renfrew I, Davies LC, et al. Trauma-induced secondary cardiac injury is associated with hyperacute elevations in inflammatory cytokines. Shock 2013
  13. 415–20. 13. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. End